Schlom J - Search Results

1

The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic.

Gabitzsch ES, Tsang KY, Palena C, David JM, Fantini M, Kwilas A, Rice AE, Latchman Y, Hodge JW, Gulley JL, Madan RA, Heery CR, Balint JP Jr, Jones FR, Schlom J. Gabitzsch ES, et al. Among authors: schlom j. Oncotarget. 2015 Oct 13;6(31):31344-59. doi: 10.18632/oncotarget.5181. Oncotarget. 2015. PMID: 26374823 Free PMC article.

2

Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.

Kantor J, Irvine K, Abrams S, Kaufman H, DiPietro J, Schlom J. Kantor J, et al. Among authors: schlom j. J Natl Cancer Inst. 1992 Jul 15;84(14):1084-91. doi: 10.1093/jnci/84.14.1084. J Natl Cancer Inst. 1992. PMID: 1619682

3

Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells.

Tsang KY, Finch MD, Primus FJ, Schlom J. Tsang KY, et al. Among authors: schlom j. Cancer Immunol Immunother. 1991;34(1):9-16. doi: 10.1007/BF01741318. Cancer Immunol Immunother. 1991. PMID: 1836975 Free PMC article.

4

In vitro and in vivo regulation of tumor antigen expression by human recombinant interferons.

Guadagni F, Schlom J, Greiner JW. Guadagni F, et al. Among authors: schlom j. Int J Rad Appl Instrum B. 1991;18(4):409-12. doi: 10.1016/0883-2897(91)90068-v. Int J Rad Appl Instrum B. 1991. PMID: 1907601

5

Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.

Tran R, Hand PH, Greiner JW, Pestka S, Schlom J. Tran R, et al. Among authors: schlom j. J Interferon Res. 1988 Feb;8(1):75-88. doi: 10.1089/jir.1988.8.75. J Interferon Res. 1988. PMID: 3130426

6

Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules.

Hodge JW, Abrams S, Schlom J, Kantor JA. Hodge JW, et al. Among authors: schlom j. Cancer Res. 1994 Nov 1;54(21):5552-5. Cancer Res. 1994. PMID: 7522961

7

Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.

Hodge JW, McLaughlin JP, Abrams SI, Shupert WL, Schlom J, Kantor JA. Hodge JW, et al. Among authors: schlom j. Cancer Res. 1995 Aug 15;55(16):3598-603. Cancer Res. 1995. PMID: 7543017

8

A recombinant vaccinia virus expressing human prostate-specific antigen (PSA): safety and immunogenicity in a non-human primate.

Hodge JW, Schlom J, Donohue SJ, Tomaszewski JE, Wheeler CW, Levine BS, Gritz L, Panicali D, Kantor JA. Hodge JW, et al. Among authors: schlom j. Int J Cancer. 1995 Oct 9;63(2):231-7. doi: 10.1002/ijc.2910630215. Int J Cancer. 1995. PMID: 7591210

9

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.

Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Tsang KY, et al. Among authors: schlom j. J Natl Cancer Inst. 1995 Jul 5;87(13):982-90. doi: 10.1093/jnci/87.13.982. J Natl Cancer Inst. 1995. PMID: 7629885

10

Enhanced interleukin-2 production in human tumor-infiltrating lymphocytes engineered by 3'-truncated interleukin-2 gene.

Yamaue H, Kashmiri SV, De Filippi R, Nieroda C, Yannelli JR, Tsang KY, Schlom J. Yamaue H, et al. Among authors: schlom j. J Immunother Emphasis Tumor Immunol. 1994 Nov;16(4):262-74. doi: 10.1097/00002371-199411000-00002. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7881635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

730 results

Search Page

Filters